Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 17.2
(6.57%)
CNY 17.2
(6.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 488.25 Million | 251.76 Million | 43.44 Million | 266.87 Million | 79.63 Million | 48.81 Million |
| Net Income | 485.78 Million | 281.43 Million | 280.89 Million | 32.64 Million | 125.74 Million | 90.58 Million |
| Depreciation & Amortization | 74.21 Million | 61.94 Million | 71.87 Million | 52.46 Million | 42.99 Million | 39.2 Million |
| Deferred income taxes | 1.98 Million | -20.25 Million | -12.08 Million | -1.64 Million | -10.15 Million | -4.01 Million |
| Stock-based compensation | 53.28 Million | 31.63 Million | 42.92 Million | - | - | - |
| Change in working capital | -85.49 Million | -184.21 Million | -118.11 Million | 77.98 Million | -171.14 Million | -130.92 Million |
| Other non-cash items | 4.54 Million | 81.23 Million | -222.05 Million | 103.78 Million | 82.03 Million | 49.94 Million |
| Investing Cash Flow | -544.63 Million | -302.72 Million | 1.52 Billion | -106.41 Million | -194.94 Million | -361.17 Million |
| Investments in PPE | -377.88 Million | -266 Million | -228.31 Million | -99.23 Million | -142.34 Million | -124.37 Million |
| Acquisitions | 8.93 Million | 413.09 | 1.96 Billion | 34.46 Thousand | 17.68 Thousand | 124.58 Million |
| Investment purchases | -165.95 Million | -50.45 Million | -12.5 Million | -33.7 Million | -114.6 Million | -317.13 Million |
| Sales/Maturities of investments | 89.17 Thousand | 65.8 Million | 22.01 Million | 22.85 Million | 25.09 Million | 80.12 Million |
| Other Investing Activities | -10 Million | -52.07 Million | -221.23 Million | 3.63 Million | 36.89 Million | -124.37 Million |
| Financing Cash Flow | -183.71 Million | -564.58 Million | -637.15 Million | -158.55 Million | 102.54 Million | 129.97 Million |
| Debt repayment | -11 Million | -35.03 Million | -1.24 Billion | -705.53 Million | -654.36 Million | -566.67 Million |
| Dividends payments | -161.95 Million | -167.83 Million | -6.46 Million | -6.46 Million | -21.79 Million | -42.2 Million |
| Common Stock Repurchased | -7.08 Million | -400.06 Million | -3.39 Million | - | - | -100.49 Million |
| Common Stock Issuance | - | 400.06 Million | 3.39 Million | - | - | - |
| Other Financing Activities | -8.44 Million | -359.58 Million | 645.14 Million | 603.1 Million | 825.63 Million | 738.85 Million |
| Accounts receivables | -57.8 Million | -163.95 Million | 9.25 Million | 38.58 Million | -54.14 Million | -117.76 Million |
| Accounts payables | 32.26 Million | 10.25 Million | -104.68 Million | 42.79 Million | -89.08 Million | 12.2 Million |
| Inventory | -61.93 Million | -10.25 Million | -39.29 Million | -1.75 Million | -17.75 Million | -21.35 Million |
| Other working capital | -4.22 Million | -20.25 Million | 16.6 Million | -1.64 Million | -10.15 Million | -109.57 Million |
| Cash at beginning of period | 492.93 Million | 1.1 Billion | 166.19 Million | 169.23 Million | 181.74 Million | 364.36 Million |
| Cash at end of period | 254.85 Million | 492.93 Million | 1.1 Billion | 166.19 Million | 169.23 Million | 181.74 Million |
| Capital Expenditure | -377.88 Million | -266 Million | -228.31 Million | -99.23 Million | -142.34 Million | -124.37 Million |
| Effect of forex changes on cash | 2.02 Million | 3.85 Million | 2.58 Million | -4.93 Million | 260.68 Thousand | -228.87 Thousand |
| Net cash flow / Change in cash | -238.07 Million | -611.68 Million | 938.41 Million | -3.03 Million | -12.5 Million | -182.61 Million |
| Free Cash Flow | 110.36 Million | -14.23 Million | -184.87 Million | 167.63 Million | -62.7 Million | -75.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 98.31 Million | 91.54 Million | 121.38 Million | 485.78 Million | 108.68 Million | 142.71 Million |
| Depreciation & Amortization | - | 22.67 Million | 22.67 Million | 74.21 Million | 74.21 Million | -33.2 Million |
| Deferred income taxes | - | - | - | 1.98 Million | - | 13.27 Million |
| Stock-based compensation | - | 13.89 Million | - | 53.28 Million | 53.28 Million | -27.42 Million |
| Change in working capital | - | -94.12 Million | - | -85.49 Million | -123.97 Million | 47.35 Million |
| Other non-cash items | 27 Million | -40.02 Million | 7.93 Million | 4.54 Million | -108.68 Million | 24.26 Million |
| Investing Cash Flow | -65.7 Million | -88.11 Million | -138.21 Million | -544.63 Million | -144.64 Million | -139.32 Million |
| Investments in PPE | -67.82 Million | -54.82 Million | -94.13 Million | -377.88 Million | -84.97 Million | -84.98 Million |
| Acquisitions | 2.09 Million | 2.6 Million | 13.18 Thousand | 8.93 Million | 5.61 Million | 68 Thousand |
| Investment purchases | - | -35 Million | -45 Million | -165.95 Million | -55.45 Million | -54.41 Million |
| Sales/Maturities of investments | - | -900 Thousand | 900 Thousand | 89.17 Thousand | 89.17 Thousand | -68 Thousand |
| Other Investing Activities | 27.99 Thousand | -33.29 Million | -44.08 Million | -10 Million | -59.66 Million | 68 Thousand |
| Financing Cash Flow | -146.01 Million | 166.19 Million | -10.72 Million | -183.71 Million | -18.08 Million | -702.66 Thousand |
| Debt repayment | -144.27 Million | -490.61 Million | -10.5 Million | -11 Million | -16.32 Million | -6.85 Million |
| Dividends payments | -1.73 Million | -325.31 Million | -275.32 Thousand | -161.95 Million | -383.61 Thousand | -479.66 Thousand |
| Common Stock Repurchased | - | - | - | -7.08 Million | -10 Thousand | 7.08 Million |
| Common Stock Issuance | - | - | - | - | - | -7.08 Million |
| Other Financing Activities | - | 907 Thousand | 50 Thousand | -8.44 Million | -1.37 Million | 6.63 Million |
| Accounts receivables | - | -70.4 Million | - | -57.8 Million | -57.8 Million | 6.11 Million |
| Accounts payables | - | - | - | 32.26 Million | - | - |
| Inventory | - | -23.72 Million | - | -61.93 Million | -61.93 Million | 41.24 Million |
| Other working capital | - | - | - | -4.22 Million | -4.22 Million | - |
| Cash at beginning of period | 345.2 Million | 236.99 Million | 254.85 Million | 492.93 Million | 272.99 Million | 245.71 Million |
| Cash at end of period | 258.2 Million | 345.2 Million | 236.99 Million | 254.85 Million | 254.85 Million | 272.99 Million |
| Capital Expenditure | -67.82 Million | -54.82 Million | -94.13 Million | -377.88 Million | -84.97 Million | -84.98 Million |
| Effect of forex changes on cash | -591.95 Thousand | 1.27 Million | 1.76 Million | 2.02 Million | 1.24 Million | 331.02 Thousand |
| Net cash flow / Change in cash | -86.99 Million | 108.2 Million | -17.85 Million | -238.07 Million | -18.13 Million | 27.28 Million |
| Free Cash Flow | 57.49 Million | -25.97 Million | 35.19 Million | 110.36 Million | 58.36 Million | 81.99 Million |
AVIFY
FRA
3833
ARVN
CPCAF
002792